Stryker Corporation $SYK Shares Bought by National Pension Service

National Pension Service grew its holdings in Stryker Corporation (NYSE:SYK) by 2.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 721,186 shares of the medical technology company’s stock after buying an additional 16,962 shares during the quarter. National Pension Service’s holdings in Stryker were worth $227,058,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Gables Capital Management Inc. acquired a new stake in Stryker in the 2nd quarter valued at $25,000. Kilter Group LLC acquired a new position in Stryker during the second quarter worth $25,000. Highland Investment Advisors LLC purchased a new position in Stryker during the second quarter valued at $25,000. Cornerstone Financial Management LLC lifted its holdings in Stryker by 66.0% during the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after purchasing an additional 31 shares in the last quarter. Finally, Godfrey Financial Associates Inc. acquired a new stake in shares of Stryker in the fourth quarter valued at about $26,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. BMO Capital Markets restated an “outperform” rating and set a $317.00 price target on shares of Stryker in a research report on Wednesday. Raymond James Financial set a $370.00 price objective on Stryker in a report on Friday, July 31st. Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Truist Financial increased their target price on Stryker from $330.00 to $340.00 and gave the company a “hold” rating in a report on Friday, July 31st. Finally, Argus set a $370.00 target price on Stryker in a research report on Thursday, July 9th. Eighteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and an average target price of $380.40.

Insider Buying and Selling

In other news, insider Debra King sold 826 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider owned 6,210 shares of the company’s stock, valued at $2,088,423. This represents a 11.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 300,000 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total value of $100,770,000.00. Following the transaction, the director owned 2,301,375 shares of the company’s stock, valued at approximately $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 351,267 shares of company stock worth $118,197,701. Company insiders own 4.60% of the company’s stock.

Stryker Stock Down 2.0%

Shares of SYK opened at $269.98 on Friday. Stryker Corporation has a 52-week low of $269.64 and a 52-week high of $392.55. The company has a market capitalization of $103.56 billion, a PE ratio of 27.98, a price-to-earnings-growth ratio of 1.72 and a beta of 0.76. The stock has a fifty day simple moving average of $325.65 and a two-hundred day simple moving average of $326.84. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the business posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts forecast that Stryker Corporation will post 15.03 EPS for the current year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.3%. Stryker’s dividend payout ratio is currently 36.48%.

About Stryker

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker’s principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.